Production (Stage)
Neuphoria Therapeutics Inc.
NEUP
$6.87
-$0.28-3.92%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 292.32% | -46.25% | -35.90% | 24.42% | 0.00% |
Total Receivables | -30.90% | -69.31% | -8.59% | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 12.97% | -91.99% | -49.63% | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 288.54% | -47.82% | -36.11% | 0.00% | -- |
|
|||||
Total Current Assets | 288.54% | -47.82% | -36.11% | 0.00% | -- |
Net Property, Plant & Equipment | -16.69% | -23.67% | -8.95% | -- | -- |
Long-term Investments | 0.52% | -5.58% | 2.46% | -- | -- |
Goodwill | 0.52% | -5.58% | 2.46% | -- | -- |
Total Other Intangibles | -3.23% | -3.12% | -3.03% | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.95% | -10.30% | 4.70% | -- | -- |
Total Assets | 69.05% | -20.72% | -17.11% | 0.00% | -- |
|
|||||
Total Accounts Payable | -51.31% | 15.44% | -40.90% | -- | -- |
Total Accrued Expenses | 28.09% | -55.79% | -25.12% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.70% | -8.78% | 6.48% | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -27.26% | -16.38% | -33.36% | 0.00% | -- |
|
|||||
Total Current Liabilities | -27.26% | -16.38% | -33.36% | 0.00% | -- |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -61.24% | -44.36% | -23.89% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 40.59% | -30.23% | -48.40% | -- | -- |
Total Liabilities | 6.69% | -24.40% | -42.45% | 0.00% | -- |
|
|||||
Common Stock & APIC | 0.60% | -0.05% | -0.10% | -- | -- |
Retained Earnings | 6.23% | -1.09% | -0.45% | 0.00% | -- |
Treasury Stock & Other | -5.27% | -53.06% | 19.43% | -- | -- |
Total Common Equity | 89.10% | -19.46% | -2.40% | -11.62% | 0.00% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 89.10% | -19.46% | -2.40% | -11.62% | 0.00% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 89.10% | -19.46% | -2.40% | -11.62% | 0.00% |
|